Table 2.
Dose levels and dose-limiting toxicities
Dose Level | Bortezomib (mg/m2) D1,4,8,11 IV Push | Belinostat (mg/m2) D1-5, 8-12 IV | Number of Patients Treated/Number of Patients DLT Evaluable | DLT Event | Median Number of Cycles (Range) |
---|---|---|---|---|---|
1 | 1.0 | 500 | 6/3 | 1.5 (1-4) | |
2 | 1.3 | 500 | 6/4 | 1.5 (1-4) | |
3 | 1.3 | 650 | 4/3 | 2 (1-2) | |
4 | 1.3 | 850 | 3/3 | 6 (2-10) | |
5* | 1.3 | 1000 | 9/6 | 3 (1-14) | |
6 | 1.3 | 1200 | 7/6 | Gr3 QTc prolongation (2 patients) | 2 (1-32) |
7 | 1.3 | 1400 | 3/2 | Gr3 QTc prolongation (2 patients) | 2 (1-8) |
Maximum tolerated dose (MTD).